In a move that has sneaker enthusiasts and music fans buzzing, rumors are swirling that Nike has allegedly extended its contract with Travis Scott until 2027.

For fans of the Jordan Brand, especially those who adore the iconic Air Jordan 1 silhouette, the anticipation for the ...

Step into the ultimate sneaker time capsule with JJ Schoeman as he unveils his jaw-dropping collection of iconic kicks. From ...

Process to adopt a child internationally and bring them back to Canada.

Carmelo Anthony crossed paths with another sports icon on Christmas Day as Real Madrid star Vinicius Junior attended the San Antonio Spurs vs. New York Knicks matchup at Madison Square Garden.

Van Drie’s vision for this dream collaboration includes two elegant Air Jordan 1 designs that incorporate Prada’s signature materials and minimalist aesthetic. The first design is predominantly black, ...

Sneakers are just as synonymous with the holidays as basketball, and hoopers have been able to count on Jordan Brand every Christmas for four decades. Jumpman is preparing to celebrate the 40th ...

There’s a lot of debate surrounding which Air Jordan sneaker silhouettes are the best. Many would argue that the 1s, 3s, 4s and 11s take the top spot. And it’s easy to see why. In 2024, those sneakers ...

The Jordanian Foreign Minister Ayman Safadi says Jordan is ready to help rebuild Syria as he holds talks with Ahmed al-Sharaa. Jordan's Foreign Minister Ayman Safadi, left, being received by Hayat ...

Sharaa: Qatar ready to invest in Syria Qatari official: Qatar will stand alongside Syrian brothers Jordanian foreign minister meets new de facto ruler in Damascus Jordan ready to help Syria ...

Early December, Amsterdam, and in the window of the Ajax club store at the Johan Cruyff Arena, Jordan Henderson’s face mingles with the tinsel. Outside, Henderson’s gaze falls on Cruyff’s ...

These effects have won GLP-1s FDA approvals for the treatment of type 2 diabetes (T2D) and obesity—while also making the drug class one of the most lucrative investment opportunities for biopharma ...